{"transactions":[{"id":795412,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2026-05-01T20:16:09.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted pursuant to the Company's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May1, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48800,"derivative":{"exercise_price":2.82,"expiration_date":"2036-05-01","underlying":"Common Stock, par value $0.0001","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0001705904-26-000002","document":"form4-05012026_080505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590426000002/form4-05012026_080505.xml","form_type":"4"}},{"id":1031145,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2025-09-29T20:15:57.000Z","date":"2025-09-25","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 25, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48800,"derivative":{"exercise_price":3.92,"expiration_date":"2035-09-25","underlying":"Common Stock, par value $0.0001","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0001104659-25-094490","document":"tm2527377-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925094490/tm2527377-4_4seq1.xml","form_type":"4"}},{"id":1397829,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2024-09-30T22:34:41.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":34900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 26, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":34900,"derivative":{"exercise_price":6.81,"expiration_date":"2034-09-26","underlying":"Common Stock, par value $0.0001","underlying_shares":34900},"source":{"system":"sec-edgar","filing":"0001104659-24-104440","document":"tm2425266-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924104440/tm2425266-4_4seq1.xml","form_type":"4"}},{"id":1771444,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2023-09-29T21:02:07.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":26100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":26100,"derivative":{"exercise_price":2.5,"expiration_date":"2033-09-28","underlying":"Common Stock, par value $0.0001","underlying_shares":26100},"source":{"system":"sec-edgar","filing":"0001104659-23-105402","document":"tm2327241-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923105402/tm2327241-8_4seq1.xml","form_type":"4"}},{"id":2148630,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2022-10-01T01:21:11.000Z","date":"2022-09-29","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 29, 2022, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":23500,"derivative":{"exercise_price":12.62,"expiration_date":"2032-09-29","underlying":"Common Stock, par value $0.0001","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001104659-22-104777","document":"tm2227177-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922104777/tm2227177-3_4seq1.xml","form_type":"4"}},{"id":2223993,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2022-06-22T20:10:15.000Z","date":"2022-06-20","kind":"exercise","acquired":false,"shares":60,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."}],"balance_after":0,"derivative":{"exercise_price":2.4,"expiration_date":"2022-07-04","underlying":"Common Stock, par value $0.0001","underlying_shares":60},"source":{"system":"sec-edgar","filing":"0001104659-22-073497","document":"tm2219109-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922073497/tm2219109-1_4seq1.xml","form_type":"4"}},{"id":2223992,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2022-06-22T20:10:15.000Z","date":"2022-06-20","kind":"exercise","acquired":false,"shares":159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 4,775 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"This option was previously reported as covering 4,775 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This option was previously reported as covering 4,775 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."}],"balance_after":0,"derivative":{"exercise_price":2.4,"expiration_date":"2022-07-04","underlying":"Common Stock, par value $0.0001","underlying_shares":159},"source":{"system":"sec-edgar","filing":"0001104659-22-073497","document":"tm2219109-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922073497/tm2219109-1_4seq1.xml","form_type":"4"}},{"id":2223991,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2022-06-22T20:10:15.000Z","date":"2022-06-20","kind":"exercise","acquired":false,"shares":60,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018."}],"balance_after":0,"derivative":{"exercise_price":2.4,"expiration_date":"2022-12-30","underlying":"Common Stock, par value $0.0001","underlying_shares":60},"source":{"system":"sec-edgar","filing":"0001104659-22-073497","document":"tm2219109-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922073497/tm2219109-1_4seq1.xml","form_type":"4"}},{"id":2223990,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2022-06-22T20:10:15.000Z","date":"2022-06-20","kind":"exercise","acquired":true,"shares":60,"price":2.4,"value":144.0,"ownership":{"direct":true},"balance_after":9179,"source":{"system":"sec-edgar","filing":"0001104659-22-073497","document":"tm2219109-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922073497/tm2219109-1_4seq1.xml","form_type":"4"}},{"id":2223989,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2022-06-22T20:10:15.000Z","date":"2022-06-20","kind":"exercise","acquired":true,"shares":159,"price":2.4,"value":381.6,"ownership":{"direct":true},"balance_after":9119,"source":{"system":"sec-edgar","filing":"0001104659-22-073497","document":"tm2219109-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922073497/tm2219109-1_4seq1.xml","form_type":"4"}},{"id":2223988,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2022-06-22T20:10:15.000Z","date":"2022-06-20","kind":"exercise","acquired":true,"shares":60,"price":2.4,"value":144.0,"ownership":{"direct":true},"balance_after":8960,"source":{"system":"sec-edgar","filing":"0001104659-22-073497","document":"tm2219109-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922073497/tm2219109-1_4seq1.xml","form_type":"4"}},{"id":2559782,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2021-09-25T00:47:35.000Z","date":"2021-09-23","kind":"grant","acquired":true,"shares":24100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 23, 2021, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":24100,"derivative":{"exercise_price":15.44,"expiration_date":"2031-09-23","underlying":"Common Stock, par value $0.0001","underlying_shares":24100},"source":{"system":"sec-edgar","filing":"0001104659-21-119490","document":"tm2128463-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465921119490/tm2128463-7_4seq1.xml","form_type":"4"}},{"id":2948421,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2020-12-12T00:00:08.000Z","date":"2020-12-10","kind":"purchase","acquired":true,"shares":2000,"price":11.99,"value":23980.0,"ownership":{"direct":true},"balance_after":8900,"source":{"system":"sec-edgar","filing":"0000899243-20-033630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320033630/doc4.xml","form_type":"4"}},{"id":2980953,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2020-11-13T23:00:14.000Z","date":"2020-11-12","kind":"sale","acquired":false,"shares":10150,"price":9.91,"value":100586.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $10.16, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6900,"source":{"system":"sec-edgar","filing":"0000899243-20-031031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320031031/doc4.xml","form_type":"4"}},{"id":3005071,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (\"RSUs\")","published_at":"2020-10-16T23:00:09.000Z","date":"2020-09-24","kind":"exercise","acquired":false,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16850},"source":{"system":"sec-edgar","filing":"0000899243-20-028536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320028536/doc4.xml","form_type":"4"}},{"id":3005070,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2020-10-16T23:00:09.000Z","date":"2020-09-24","kind":"exercise","acquired":true,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17050,"source":{"system":"sec-edgar","filing":"0000899243-20-028536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320028536/doc4.xml","form_type":"4"}},{"id":3021644,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2020-09-28T22:00:09.000Z","date":"2020-09-24","kind":"grant","acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 24, 2020, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":25500,"derivative":{"exercise_price":12.03,"expiration_date":"2030-09-24","underlying":"Common Stock, par value $0.0001","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0000899243-20-026410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320026410/doc4.xml","form_type":"4"}},{"id":3097473,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (\"RSUs\")","published_at":"2020-06-30T01:52:43.000Z","date":"2020-06-25","kind":"exercise","acquired":true,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date."}],"balance_after":16850,"derivative":{"underlying":"Common Stock","underlying_shares":16850},"source":{"system":"sec-edgar","filing":"0000899243-20-017831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320017831/doc4.xml","form_type":"4"}},{"id":3703679,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2019-01-04T22:18:29.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001012975-19-000039","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000101297519000039/edgar.xml","form_type":"4"}},{"id":4184697,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2017-10-18T00:16:29.000Z","date":"2017-10-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":2.5,"exercise_date":"2018-04-30","expiration_date":"2027-10-13","underlying":"Common Stock, par value $0.0001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001012975-17-000767","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000101297517000767/edgar.xml","form_type":"4"}},{"id":4329927,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (option to buy)","published_at":"2017-05-09T00:37:32.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":1791,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":1791,"derivative":{"exercise_price":0.59,"exercise_date":"2017-05-04","expiration_date":"2023-12-31","underlying":"Common Stock, par value $0.0001","underlying_shares":1791},"source":{"system":"sec-edgar","filing":"0000899243-17-012363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924317012363/doc4.xml","form_type":"4"}},{"id":4329926,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (option to buy)","published_at":"2017-05-09T00:37:32.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":1791,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":1791,"derivative":{"exercise_price":0.08,"exercise_date":"2017-05-04","expiration_date":"2022-12-31","underlying":"Common Stock, par value $0.0001","underlying_shares":1791},"source":{"system":"sec-edgar","filing":"0000899243-17-012363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924317012363/doc4.xml","form_type":"4"}},{"id":4329925,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (option to buy)","published_at":"2017-05-09T00:37:32.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":1791,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":1791,"derivative":{"exercise_price":0.08,"exercise_date":"2017-05-04","expiration_date":"2022-07-04","underlying":"Common Stock, par value $0.0001","underlying_shares":1791},"source":{"system":"sec-edgar","filing":"0000899243-17-012363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924317012363/doc4.xml","form_type":"4"}},{"id":4329924,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (option to buy)","published_at":"2017-05-09T00:37:32.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":4775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":4775,"derivative":{"exercise_price":0.08,"exercise_date":"2017-05-04","expiration_date":"2022-07-04","underlying":"Common Stock, par value $0.0001","underlying_shares":4775},"source":{"system":"sec-edgar","filing":"0000899243-17-012363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924317012363/doc4.xml","form_type":"4"}},{"id":4329923,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50274,"kind":"person","name":"Schafer Klaus","position":1,"cik":"0001705904","reported_name":"Schafer Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-05-09T00:37:32.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":5998,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement, the then outstanding shares of Altimmune's capital stock was converted into the right to receive a number of shares of the Issuer's common stock, par value $0.0001 on a 0.749106:1 basis upon the closing of the merger."}],"balance_after":5998,"source":{"system":"sec-edgar","filing":"0000899243-17-012363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924317012363/doc4.xml","form_type":"4"}}]}